In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...

George Soros’ Soros Fund Management disclosed in an SEC filing its holdings as of December 31, 2024. The fund’s new buys during the fourth ...

The biggest fallers on the FTSE 100 were Schroders, down 12p to 371.6p, IAG, down 8.9p to 338.5p, AstraZeneca, down 256p to ...

In the commodities sector, demand for gold and other precious metals funds reached a four-and-a-half-month high as investors poured $1.41 billion into these funds. Energy funds also saw a slight ...

Global sectoral equity funds also saw a net $258 million worth of sales, the first weekly outflow in six weeks. Consumer ...

Moderna (NASDAQ:MRNA) stock drops ~5% as its Q4 2024 results show revenue beat but earnings miss expectations. Read more here ...

Total Revenue of $560 million, exceeding guidanceCrysvita® revenue of $410 million and Dojolvi® revenue of $88 million2025 Financial ...

Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.

Marine Systems, a key segment for GD, continues to face margin pressure despite robust sales growth, as supply chain ...

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

Welcome to the fourth-quarter and full-year 2024 financial results conference call and webcast for Zoetis. Hosting the call ...

NEW YORK - Waste Connections Inc (NYSE: WCN) reported fourth-quarter earnings that missed analyst expectations, with revenue also falling short of estimates. The company's stock edged down 0.2% ...